Use of mutation profiling of breast cancer using sequenom technology to detect distinct mutation patterns in triple-negative compared to receptor-positive cancers.
Santarpia L, Gonzalez-Angulo A, Qi Y, Stemke-Hale K, Wang B, Booser D, Hortobagyi G, Symmans W, Di Leo A, Pusztai L. Use of mutation profiling of breast cancer using sequenom technology to detect distinct mutation patterns in triple-negative compared to receptor-positive cancers. Journal Of Clinical Oncology 2010, 28: 1039-1039. DOI: 10.1200/jco.2010.28.15_suppl.1039.Peer-Reviewed Original Research